This page covers complicated pregnancy thesis topics across hypertensive disorders of pregnancy, gestational diabetes mellitus, antepartum haemorrhage and placental complications, preterm labour and preterm prelabour rupture of membranes, foetal growth restriction and abnormal foetal growth, multiple pregnancy, maternal anaemia and haematological disorders, thyroid and other medical disorders, infections complicating pregnancy, and obstetric emergencies or severe maternal complications for MD Obstetrics and Gynaecology candidates. The emphasis is on complicated pregnancy research topics that can be completed within one thesis period using antenatal, labour-room, ward, intensive-care, laboratory, ultrasonography and delivery data already generated during routine care. A shortlisted question should then be converted into a focused obstetrics and gynaecology protocol and a submission-ready obstetrics and gynaecology synopsis using one clearly defined index complication and one prespecified time anchor.
Last reviewed and updated: September 2026 · 2026–27 admissions
Not the obstetrics and gynaecology subspeciality you need? Complicated pregnancy is one section of our full obstetrics and gynaecology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
All Obstetrics and Gynaecology Topics →📌 Updated for 2026–2027 MD Obstetrics and Gynaecology Complicated Pregnancy admissions
The content has been reviewed for current high-risk pregnancy definitions, practical resident-level study designs, overlapping maternal disorders, foetal outcomes and severe maternal morbidity.
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Already have your thesis title?
Generate the full complicated pregnancy protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocolAlongside complicated pregnancy protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →Complicated pregnancy research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the complicated pregnancy research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the complicated pregnancy research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a complicated pregnancy research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A complicated pregnancy IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning complicated pregnancy research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the complicated pregnancy research proposal is the document assessed at the start of it.
Kuwait — KIMS. A complicated pregnancy study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the complicated pregnancy proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A complicated pregnancy dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full complicated pregnancy research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a complicated pregnancy PhD or MMed proposal →🔥 Trending research areas in Complicated Pregnancy for 2026–27
Current research increasingly focuses on earlier risk stratification, continuous monitoring and reproducible prediction of severe maternal and foetal complications rather than simple descriptive case series.
A complicated pregnancy protocol must define one index disorder using named diagnostic criteria, the gestational-age window, whether the pregnancy is singleton or multiple, the first qualifying time point and which measurements are taken before treatment changes them. This is essential because blood pressure, glucose, haemoglobin, platelet count, liver enzymes, infection markers, foetal growth, Doppler indices and organ dysfunction can change rapidly after admission, medication, transfusion, delivery or other intervention.
Overlapping complications must be handled explicitly. Preeclampsia may coexist with foetal growth restriction, gestational diabetes with maternal obesity, placenta previa with placenta accreta spectrum, preterm prelabour rupture of membranes with infection, and maternal anaemia with haemorrhage. The protocol should state whether such women are excluded, assigned to a prespecified primary diagnosis, analysed in separate strata or retained with statistical adjustment rather than silently appearing in several comparison groups.
Outcome windows must be fixed. Maternal outcomes such as intensive-care admission, organ dysfunction, transfusion, emergency hysterectomy or death and foetal outcomes such as preterm birth, birth weight, Apgar score, neonatal intensive-care admission or stillbirth should be defined with a clear ascertainment period. The study should distinguish characteristics present at the index assessment from complications that develop later.
The synopsis is the concise institutional submission describing the problem, objectives, broad population, design and principal variables. The full protocol must convert those statements into reproducible case definitions. For example, a study of preeclampsia should specify the blood-pressure technique, qualifying readings, organ-dysfunction criteria, timing of laboratory values and whether measurements obtained after antihypertensive therapy or magnesium sulphate are eligible for the primary analysis.
The protocol should also define how competing diagnoses are classified, which variable represents baseline severity, how referral cases already treated elsewhere are handled, whether foetal outcomes are analysed per pregnancy or per baby in multiple gestation, and how missing admission values are treated. Without these rules, apparently similar high-risk groups can represent very different stages of disease.
Sample size should follow the primary endpoint. A prevalence study needs an expected proportion and desired precision; a comparison of women with and without a complication needs an expected between-group difference; and a predictor study needs enough outcome events for the number of variables planned in the final model. Rare outcomes such as maternal death, emergency hysterectomy or disseminated intravascular coagulation are usually unsuitable as the sole primary endpoint of a small single-centre thesis unless the centre has sufficient case volume.
The denominator must match the clinical unit. In singleton pregnancy the woman and pregnancy usually coincide, but twin pregnancy creates one mother and two foetuses, and neonatal analyses can therefore contain correlated outcomes from the same pregnancy. Maternal complications should use the woman as the denominator, while foetal or neonatal analyses in multiple gestation should either use pregnancy-level summaries or statistical methods that account for clustering of co-twins.
Multivariable analysis should be used cautiously when gestational age, obesity, hypertension, diabetes, anaemia, multiple pregnancy and referral status all influence both exposure and outcome. Variables measured after treatment or after the outcome begins should not be inserted as though they were baseline predictors. If severity scores or laboratory thresholds are derived from the same dataset, they should be described as locally derived and require separate validation before being presented as general clinical cut-offs.
For a 2026 MD Obstetrics and Gynaecology admission, begin with one complication that is frequent enough in the department and has a reproducible definition, such as hypertensive disorders, gestational diabetes, antepartum haemorrhage, preterm labour, foetal growth restriction, twin pregnancy, maternal anaemia or infection. Check monthly case volume, whether the first qualifying clinical and laboratory values can be retrieved, and whether the chosen maternal or foetal outcome is routinely recorded before finalising the topic.
Suitable designs include descriptive and analytical cross-sectional studies, comparative studies, retrospective or prospective cohorts, diagnostic or prognostic studies and selected case-control designs. The design should match the timing of the question. Characteristics measured at one clinical time point may be cross-sectional, but a maternal measurement followed by delivery, organ dysfunction or neonatal outcome is longitudinal even if follow-up lasts only until discharge.
Settle the index complication, diagnostic criteria, gestational-age limits, baseline time point, treatment status, primary outcome and major overlapping disorders before writing the objectives. Also decide how referred women already treated elsewhere, multiple pregnancies, repeat admissions, missing baseline investigations and women who satisfy criteria for more than one high-risk condition will be handled.
Yes for a descriptive service profile, but usually not for an analytical study that intends to identify predictors or compare outcomes. Hypertensive disease, gestational diabetes, placenta previa, preterm prelabour rupture of membranes, foetal growth restriction, twin pregnancy and maternal sepsis have different biology, diagnostic criteria and treatment pathways. Pooling them into one exposure called “high-risk pregnancy” can produce an average that is clinically difficult to interpret. A stronger analytical thesis usually chooses one index complication and treats the others as exclusion criteria, prespecified subgroups or confounders.
The synopsis is the shorter academic submission used for topic approval or registration. The protocol is the operational document that fixes the diagnostic definition, baseline time point, eligibility criteria, laboratory and imaging measurements, treatment status, maternal and foetal outcomes, handling of overlapping disorders, missing data and the statistical analysis. The final thesis should use those definitions unchanged rather than selecting the most favourable severity measure after examining the results.
The protocol should state which blood tests, ultrasonography, Doppler, cardiotocography, glucose measurements and other assessments are already part of standard maternal care and which, if any, are added solely for research. Pregnant participants and foetuses should not be exposed to research-only ionising radiation, contrast studies or invasive procedures merely to strengthen a thesis. Research-only venepuncture should be avoided when routine samples are sufficient; where additional blood is genuinely necessary, the indication and permitted blood volume should be stated.
Prospective participants should provide informed consent. If pregnant adolescents are eligible, guardian consent and age-appropriate assent from about seven years should be addressed according to institutional requirements and applicable law. Retrospective record-based work may qualify for an ethics-approved waiver of individual consent. Exported ultrasound or other DICOM images should have identifiers removed before research analysis outside the clinical system, and separate consent is required for identifiable photographs or video. The protocol should name the escalation pathway for severe hypertension, worsening preeclampsia, major haemorrhage, suspected sepsis, severe anaemia, abnormal foetal Doppler, threatened preterm birth or another actionable finding so that clinical management is never delayed for research.
The sharpest error is failing to fix a common time-zero. In complicated pregnancy, nearly every important variable changes with disease progression and treatment. A platelet count at admission cannot be compared directly with the lowest platelet count before delivery, a blood pressure before antihypertensive treatment cannot be mixed with a treated value, and a glucose value at diagnosis cannot be mixed with one obtained after dietary or insulin therapy. If the protocol simply records the “worst” or “available” value, apparent associations may reflect when the measurement was taken rather than true disease severity.
The protocol should therefore nominate a baseline such as the first qualifying assessment before treatment, or another clinically justified fixed window, and use that anchor consistently. Later deterioration can be analysed as an outcome or longitudinal change, but it should not be silently substituted for baseline exposure.
An MD synopsis is usually a focused dissertation plan designed for completion during residency using a defined obstetric population and routinely available investigations. A PhD proposal is expected to justify a broader knowledge gap, a more extensive methodology and a programme of original research that may include multicentre recruitment, biomarkers, longer follow-up or external validation.
Residents outside the Indian MD pathway should align the project with the requirements of their training body. This includes the mandatory board research project required within SCFHS and Saudi Board training, Arab Board of Health Specializations research requirements, and institutional or programme research processes linked to DHP, DHA, DOH and MOHAP. The clinical question may remain similar, but supervision, ethics, submission format and completion milestones should follow the relevant programme.
Register after confirming the exact complication, diagnostic criteria, expected case volume, baseline time point, availability of the primary outcome and agreement with the guide on how overlapping disorders will be handled. Registration should occur before prospective recruitment or research-specific data collection begins. For retrospective work, fix the study period, eligibility criteria and analysis plan before extracting outcomes so that case selection is not influenced by severity or outcome already known to the investigator.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol